Genmab A/S
GMAB
$20.50
-$0.23-1.11%
NASDAQ
03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
---|---|---|---|---|---|
Net Income | 1.13B | 1.13B | 683.20M | 803.92M | 795.81M |
Total Depreciation and Amortization | 72.60M | 69.60M | 61.54M | 57.45M | 52.93M |
Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
Total Other Non-Cash Items | 79.28M | 31.28M | 338.04M | 157.44M | 130.39M |
Change in Net Operating Assets | -93.63M | -107.63M | -104.52M | -42.63M | -157.56M |
Cash from Operations | 1.19B | 1.12B | 978.26M | 976.17M | 821.56M |
Capital Expenditure | -34.93M | -26.93M | -23.17M | -31.88M | -42.16M |
Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
Cash Acquisitions | -1.77B | -1.77B | -1.77B | -1.77B | -- |
Divestitures | -- | -- | -- | -- | -- |
Other Investing Activities | 537.92M | 362.92M | 283.63M | 406.54M | -352.56M |
Cash from Investing | -1.26B | -1.43B | -1.51B | -1.39B | -394.71M |
Total Debt Issued | -- | -- | -- | -- | -- |
Total Debt Repaid | -38.00M | -39.00M | -64.00M | -63.00M | -73.00M |
Issuance of Common Stock | 71.00M | 79.00M | 77.00M | 74.00M | 129.00M |
Repurchase of Common Stock | -3.37B | -3.45B | -3.45B | -3.15B | -136.00M |
Issuance of Preferred Stock | -- | -- | -- | -- | -- |
Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
Total Dividends Paid | -- | -- | -- | -- | -- |
Other Financing Activities | -- | -- | -- | -- | -- |
Cash from Financing | -493.47M | -565.47M | -569.08M | -525.48M | -84.23M |
Foreign Exchange rate Adjustments | 110.99M | 101.99M | -89.40M | -45.05M | -44.08M |
Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
Net Change in Cash | -453.99M | -769.99M | -1.19B | -986.67M | 298.54M |